Epstein-Barr Virus Contributes to Multiple Sclerosis, Major 2026 Study Claims

A major study took a closer look at how the Epstein-Barr virus is capable of increasing an individual’s risk of multiple sclerosis (MS).

Yoshiaki Yasumizu at Yale School of Medicine and his team examined the medical data of more than 600,000 people, which revealed that the virus can do the following:

• Hijack immune cells
• Disrupt the normal functioning of the immune system
• Activate genes that increase the risk of MS

While experts welcome the findings, they claim that further research is needed on how the condition develops in order to better treat MS.

• SEE ALSO: “Blew My Mind”: Autoimmune Conditions Capable of Producing Psychosis

Disability Benefits for Multiple Sclerosis in Canada

MS can have a profound impact on an individual’s ability to perform their job duties — even with appropriate treatment.

For Canadians who can’t work due to this debilitating condition, short-term disability (STD) and long-term disability (LTD) benefits can provide a crucial financial lifeline.

How These Benefits Help

• STD: Provides temporary financial support for individuals unable to perform their job duties.
• LTD: Offers income replacement for individuals unable to return to work for an extended period of time.

To qualify for STD or LTD benefits, medical documentation is essential to demonstrate how your condition prevents you from working.

Sadly, insurance companies often deny legitimate LTD claims — including in cases involving MS — adding unnecessary stress to an already difficult situation.

SEE ALSO
• Medical Conditions that Qualify for Disability in Canada
• Denied LTD? Seek Legal Advice Before Appealing the Decision
• Pocket Disability Lawyer: Real-Time Insights on Your Rights
• Canada Post Worker Denied LTD During Cancer Battle

Disclaimer: The materials provided in this article are for general informational purposes only and DO NOT constitute legal advice. For advice specific to your situation, please consult a legal representative at Samfiru Tumarkin LLP.